Biovest Takes 9 Percent Stake in MDxHealth | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – MDxHealth today said that as part of its recent private placement, which brought in $11.7 million, investment firm Biovest has obtained a 9 percent stake in the company.

Biovest's president is Rudi Mariën, who is a co-founder and chairman of Innogenetics, a Belgium-based molecular diagnostics firm.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.